Game-Changers in Non-Alcoholic Steatohepatitis (NASH) Treatment: Insights into Novel Drug Classes
Available NASH Therapeutic Strategies Non-alcoholic steatohepatitis (NASH), a progressive form of liver disease, continues to raise global health concerns because of its potential to progress into cirrhosis and ultimately liver failure. At present, there is no FDA-approved medicine for NASH, though patients are often managed with lifestyle modifications and certain off-label drugs such as...
0 Commentaires 0 Parts 54 Vue 0 Aperçu
Commandité